Quality of life and adherence to HAART in HIV-infected patients

Revista de Saude Publica

Volumn 44, Issue 4, 2010, Pages 743-749

  Geocze, Luciana ^a   Mucci, Samantha ^a   de Marco, Mario Alfredo ^a   Nogueira Martins, Luiz Antonio ^a   de Albuquerque Citero, Vanessa ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acquired immunodeficiency syndrome, prevention control; Anti HIV agents; HIV long term survivors; Medication adherence; Quality of life; Review

Indexed keywords

EID: 77955409198     PISSN: 00348910     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0034-89102010000400019     Document Type: Review

References (29)

1. Bader A, Kremer H, Erlich-Trungenberger I, Rojas R, Lohmann M, Deobald O, et al. An adherence typology: coping, quality of life, and physical symptoms of people living with hiv/aids and their adherence to antiretroviral treatment. Med Sci Monit. 2006;12(12):CR493-500.
2. Bonjoch A, Paredes R, Galvez J, Miralles C, Videla S, Martinez E, et al. Antiretroviral treatment simplification with 3 NRTIs or 2 NRTIs plus nevirapine in HIV-1 infected patients treated with successful first line HAART. J Acquir Immune Defic Syndr. 2005;39(3):313-6. DOI:10.1097/01.qai.0000164249.33851.3a
3. Carr AJ, Higginson IJ. Measuring quality of life: Are quality of life measures patient centered? Br Med J. 2001;322(7298):1357-60. DOI:10.1136/bmj.322.7298.1357
4. Chiou PY, Kuo BI, Lee MB, Chen YM, Chuang P, Lin LC. Programme of symptom management for improving quality of life and drug adherence in AIDS/HIV patients. J Adv Nurs. 2006;(2):169-9.
5. Gifford AL, Groessl EJ. Chronic disease self-management and adherence to hiv medications. J Acquir Immune Defic Syndr. 2002;31 (Suppl 3):163-6.
6. Goujard C, Bernard N, Sohier N, Peyramond D, Lançon F, Chwalow J, et al. Impact of a patient education program on adherence to hiv medication: a randomized clinical trial. J Acquir Immune Defic Syndr. 2003;34(2):191-4. DOI:10.1097/00126334-200310010-00009
7. Jia H, Uphold CR, Wu S, Reid K, Findley K, Duncan PW. Health-related quality of life among men with HIV infection: effects of social support, coping and depression. AIDS Patient Care STDS. 2004;18(10):594-603. DOI:10.1089/apc.2004.18.594
8. Kalichman A, Bueno SM. Vinte anos de assistência aos portadores de DST-HIV/AIDS no estado de São Paulo. Pratica Hosp. 2004;6(33).
9. Klitzman RL, Kirshenbaum SB, Dodge B, Remin RH, Ehrhardt AA, Johnson MO, et al. Intricacies and interrelationships between HIV disclosure and HAART: a qualitative study. AIDS Care. 2004;16(5):628-40. DOI:10.1080/09540120410001716423
10. Levi GC, Vitória MA. Fighting against AIDS: the Brazilian experience. AIDS. 2002;16(18):2373-83. DOI:10.1097/00002030-200212060-00001
11. Liu C, Weber K, Lerch V, Schneider MF, Sharp GB, Gorapaju L, et al. Association between complementary and alternative medicine use and adherence to highly active antiretroviral therapy in the Women' Interagency HIV Study. J Altern Complement Med. 2007;13(10):1053-6. DOI:10.1089/acm.2007.0590
12. Luszczynska A, Sarkar Y, Knoll N. Received social support, self-efficacy, and finding benefits in disease as predictors of physical functioning and adherence to antiretroviral therapy. Patient Educ Couns. 2007;66(1):37-42. DOI:10.1016/j.pec.2006.10.002
13. Mannheimer SB, Matts J, Telzak E, Chesney M, Child C, Wu AW, et al. Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. AIDS Care. 2005;17(1):10-22. DOI:10.1080/09540120412331305098
14. Martinez-Picado J, Negredo E, Ruiz L, Shintani A, Fumaz CR, Zala C, et al. Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trial. Ann Intern Med. 2003;139(2):81-9.
15. Melchior R, Nemes MIB, Basso CR, Castanheira ERL, Britto e Alves MTS, Buchalla CM, et al. Avaliação da estrutura organizacional da assistência ambulatorial em HIV/Aids no Brasil. Rev Saude Publica. 2006;40(1):143-51. DOI:10.1590/S0034-89102006000100022
16. Parsons TD, Braaten AJ, Hall CD, Robertson KR. Better quality of life with neuropsychological improvement on Haart. Health Qual Life Outcomes. 2006;4:11. DOI:10.1186/1477-7525-4-11
17. Patrick DL, Erikson P. What constitutes quality of life? Concepts and dimensions. Clin Nutr. 1988;7:53-63.
18. Penedo FJ, Gonzalez JS, Dahn JR, Antoni M, Malow R, Costa P, et al. Personality, quality of life and Haart adherence among men and women living with HIV/AIDS. J Psychosom Res. 2003;54(3):271-8. DOI:10.1016/S0022-3999(02)00482-8
19. Puigventós F, Riera M, Delibes C, Peñaranda M, de la Fuente L, Boronat A. Adherence to antiretroviral drug therapy. A systematic review. Med Clin (Barc). 2002;119(4):130-7.
20. Reis AC, Santos, EM, Cruz, MM. A mortalidade por aids no Brasil: um estudo exploratório de sua evolução temporal. Epidemiol Serv Saude. 2007;16(3):195-205.
21. Remor E, Milner-Moskovics J, Preussler G. Adaptação brasileira do "Cuestionario para la Evaluación de la Adhesión al Tratamiento Antiretroviral" Rev Saude Publica. 2007;41(5):685-94. DOI:10.1590/S0034-89102006005000043
22. Ruiz L, Paredes R, Gómez G, Romeu J, Domingo P, Pérez-Alvarez N, et al. Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-nfected patients. AIDS. 2007;21(2):169-78. DOI:10.1097/QAD.0b013e328011033a
23. Ruiz-Pérez I, Olry de Labry-Lima A, López-Ruz MA, del Arco-Jiménez A, Rodríguez-Baño J, Causse-Prados M, et al. Clinical status, adherence to haart and quality of life in hiv-infected patients receiving antiretroviral treatment. Enferm Infecc Microbiol Clin. 2005;23(10):581-5.
24. Ruiz-Pérez I, Olry de Labry-Lima A, Prada-Pardal JL, Rodríguez-Baño J, Causse-Prados M, López-Ruz MA, et al. Impact of demographic and psychosocial factors on adherence to antiretroviral treatment. Enferm Infecc Microbiol Clin. 2006;24(6):373-8.
25. Santos J, Palacios R, López M, Gálvez MC, Lozano F, de la Torres J, et al. Simplicity and efficacy of a once-daily antiretroviral regimen with didanosine, lamivudine, and efavirenz in naïve patients: the VESD study. HIV Clin Trials. 2005;6(6):320-8. DOI:10.1310/1XAE-BB0W-QN5R-AJGJ
26. Sherr L, Lampe F, Norwood S, Leake-Date H, Fisher M, Edwards S, et al. Successive switching of antiretroviral therapy is associated with high psychological and physical burden. Int J STD AIDS. 2007;18(10):700-4. DOI:10.1258/095646207782193821
27. Summaries for patients. Alternating drug regimens to treat HIV infection. Ann Intern Med. 2003;139(2):I16.
28. HOQol Group. The development of the World Health Organization Quality of Life Assessment instrument (The WHOQol). In: Orley J, Kuyken W, editors. Quality of life assessment: international perspectives. Heidleberg: Springer;1994. p.43
29. Wu AW, Snyder CF, Huang IC, Skolasky R, McGruder HF, Celano AS, et al. A randomized trial of the impact of a programmable medication reminder device on quality of life in patients with AIDS. AIDS Patient Care STDS. 2006;20(11):773-81. DOI:10.1089/apc.2006.20.773